Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Assets (QoQ)Assets Growth (1y)Assets Growth (3y)Assets Growth (5y)Capital Expenditures (QoQ)Capital Expenditures Growth (1y)Capital Expenditures Growth (3y)Capital Expenditures Growth (5y)Cash & Equivalents (QoQ)Cash & Equivalents Growth (1y)Cash & Equivalents Growth (3y)Cash & Equivalents Growth (5y)Cash from Investing Activities (QoQ)Cash from Investing Activities Growth (1y)Cash from Investing Activities Growth (3y)Cash from Investing Activities Growth (5y)Cash from Operations (QoQ)Cash from Operations Growth (1y)Cash from Operations Growth (3y)Cash from Operations Growth (5y)Dividends Paid - Common (QoQ)Dividends Paid - Common Growth (1y)Dividends Paid - Common Growth (3y)Dividends Paid - Common Growth (5y)EBIT (QoQ)EBIT Growth (1y)EBIT Growth (3y)EBIT Growth (5y)EBIT Margin (QoQ)EBIT Margin Growth (1y)EBIT Margin Growth (3y)EBIT Margin Growth (5y)EBITDA Margin (QoQ)EBITDA Margin Growth (1y)EBITDA Margin Growth (3y)EBITDA Margin Growth (5y)EBT (QoQ)EBT Growth (1y)EBT Growth (3y)EBT Growth (5y)EBT Margin (QoQ)EBT Margin Growth (1y)EBT Margin Growth (3y)EBT Margin Growth (5y)EPS (Basic) (QoQ)EPS (Basic) Growth (1y)EPS (Basic) Growth (3y)EPS (Basic) Growth (5y)EPS (Weighted Average and Diluted) (QoQ)EPS (Weighted Average and Diluted) Growth (1y)EPS (Weighted Average and Diluted) Growth (3y)EPS (Weighted Average and Diluted) Growth (5y)Enterprise Value (QoQ)Enterprise Value Growth (1y)Enterprise Value Growth (3y)Enterprise Value Growth (5y)FCF Margin (QoQ)FCF Margin Growth (1y)FCF Margin Growth (3y)FCF Margin Growth (5y)FCF Payout Ratio (QoQ)FCF Payout Ratio Growth (1y)FCF Payout Ratio Growth (3y)FCF Payout Ratio Growth (5y)Free Cash Flow (QoQ)Free Cash Flow Growth (1y)Free Cash Flow Growth (3y)Free Cash Flow Growth (5y)Gross Margin (QoQ)Gross Margin Growth (1y)Gross Margin Growth (3y)Gross Margin Growth (5y)Gross Profit (QoQ)Gross Profit Growth (1y)Gross Profit Growth (3y)Gross Profit Growth (5y)Net Cash Flow (QoQ)Net Cash Flow Growth (1y)Net Cash Flow Growth (3y)Net Cash Flow Growth (5y)Net Income (QoQ)Net Income Growth (1y)Net Income Growth (3y)Net Income Growth (5y)Net Income towards Common Stockholders (QoQ)Net Income towards Common Stockholders Growth (1y)Net Income towards Common Stockholders Growth (3y)Net Income towards Common Stockholders Growth (5y)Net Margin (QoQ)Net Margin Growth (1y)Net Margin Growth (3y)Net Margin Growth (5y)Operating Income (QoQ)Operating Income Growth (1y)Operating Income Growth (3y)Operating Income Growth (5y)Operating Margin (QoQ)Operating Margin Growth (1y)Operating Margin Growth (3y)Operating Margin Growth (5y)Profit After Tax (QoQ)Profit After Tax Growth (1y)Profit After Tax Growth (3y)Profit After Tax Growth (5y)Property, Plant & Equipment (Net) (QoQ)Property, Plant & Equipment (Net) Growth (1y)Property, Plant & Equipment (Net) Growth (3y)Property, Plant & Equipment (Net) Growth (5y)Return on Capital Employed (QoQ)Return on Capital Employed Growth (1y)Return on Capital Employed Growth (3y)Return on Capital Employed Growth (5y)Revenue (QoQ)Revenue Growth (1y)Revenue Growth (3y)Revenue Growth (5y)Share-based Compensation (QoQ)Share-based Compensation Growth (1y)Share-based Compensation Growth (3y)Share-based Compensation Growth (5y)Shareholder's Equity (QoQ)Shareholder's Equity Growth (1y)Shareholder's Equity Growth (3y)Shareholder's Equity Growth (5y)Tax Rate (QoQ)Tax Rate Growth (1y)Tax Rate Growth (3y)Tax Rate Growth (5y)
Income Statement
Others
Ratios

Dolby Laboratories (DLB) FCF Payout Ratio Growth (1y) (2016 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Cover Growth (1y) (Qtr)
1 Relx 81.40 Bn 81.16 Bn - -
2 Rentokil Initial 79.56 Bn 78.10 Bn - -
3 Cintas 69.26 Bn 69.08 Bn 1.45 Bn 12.14%
4 Copart 33.09 Bn 28.01 Bn 971.24 Mn -
5 UL Solutions 20.56 Bn 20.32 Bn 381.00 Mn -34.36%
6 Global Payments 19.88 Bn 14.69 Bn 1.70 Bn -186.77%
7 Rb Global 19.08 Bn 18.89 Bn 869.50 Mn -44.92%
8 Aramark 13.57 Bn 13.16 Bn 426.35 Mn -46.88%
9 Amentum Holdings 5.65 Bn 5.74 Bn 345.00 Mn -67.88%
10 Dolby Laboratories 5.15 Bn 4.56 Bn 350.90 Mn 331.33%

Historic Data

Download Data 🔒
DateValue
Mar 27, 2026 331.33%
Dec 26, 2025 -96.54%
Sep 26, 2025 2.39%
Jun 27, 2025 -75.38%
Mar 28, 2025 13.76%
Dec 27, 2024 -97.45%
Sep 27, 2024 -13.85%
Jun 28, 2024 208.14%
Dec 29, 2023 228,414.51%
Dec 30, 2022 -99.63%
Apr 1, 2022 -187.42%
Dec 31, 2021 1,229.82%
Sep 24, 2021 135.17%
Jun 25, 2021 -74.45%
Dec 25, 2020 203.50%
Sep 25, 2020 -484.25%
Jun 26, 2020 93.47%
Dec 27, 2019 -92.86%
Sep 27, 2019 -4.61%
Jun 28, 2019 117.69%
Mar 29, 2019 224.52%
Dec 28, 2018 206.10%
Sep 28, 2018 -22.81%
Jun 29, 2018 -65.42%
Dec 29, 2017 -1,204.22%
Sep 29, 2017 -75.11%
Dec 30, 2016 1,343.58%
Sep 30, 2016 437.45%